Poster Session

Friday, 19 March 2010 17:00 - 18:30, Grand Ballroom Foyer

Valnoctamide as a valproate substitute with low teratogenic potential in mania: double-blind controlled clinical trial
  • Prof RH Belmaker, Ben Gurion University, Israel
Rescuing childhood: understanding bipolar disorders in children and adolescents
  • Dr Rosalie Greenberg, Overlook Hospital, United States
Tobacco smoking and bipolar disorder: evidence for a worsened course of illness
  • Dr Seetal Dodd, University of Melbourne, Australia
Associations between diet quality and depressed mood in adolescents: results from the healthy neighbourhoods study
  • Professor Michael Berk, Orygen Youth Health Research Centre, University of Melbourne, Australia
Under recognition of bipolar disorder among Hispanics attending a rural alcohol and drug treatment program in Southern California
  • Alvaro Camacho, University of California, San Diego, United States
The relationship attachment style, personality and temperament in patient with bipolar disorder and their children: a controlled study
  • Dr Sermin Kesebir, Adnan Menders University, Turkey
The impact of depressive or anxious caregiver on treatment adherence in bipolar patients
  • Dr Sermin Kesebir, Adnan Menderes University, Turkey
A comparison between the bipolar disorders with comorbidity and without comorbidity
  • Dr Sermin Kesebir, Adnan Menderes University, Turkey
A comparison of the phenomenology and illness course of major depressive episodes in major depressive disorder and bipolar I and bipolar II disorders
  • Mr Andrew Frankland, University of New South Wales, Australia
Differences of manic prodrome and coping strategy between psychotic and nonpsychotic bipolar patients
  • Mr Hyun Sang Cho, Institute of Behaviral Science in Medicine, Yonsei University College of Medicine, Korea
  • Mr Vin Ryu, Institute of Behaviral Science in Medicine, Yonsei University College of Medicine, Korea
Insight and cognitive functions in subjects with bipolarity I
  • Fernando Ivanovic-Zuvic, Clinica Psiquiatrica Universitaria, Hospital Clinico, Facultad de Medicina, Universidad de Chile, Chile
Differences in clinical features and comorbidy between bipolar I and bipolar II disorders
  • Dr Ji Hyun Baek, Department of Psychiatry, Sungkyunkwan University School of Medicine, Samsung Medical Center, Korea
  • Dr Jungmi Choi, Sungkyunkwan University School of Medicine, Samsung Medical Center, Korea
  • Dr Dong Yeon Park, Seoul National Hospital, Korea
  • RN-BSN Ji Sun Choi, Sungkyunkwan University School of Medicine, Samsung Medical Center, Korea
  • MA Jihae Noh, Sungkyunkwan University, Korea
  • Ms Eun Young Cho, Department of Psychiatry, Sungkyunkwan University School of Medicine, Korea
  • Dr Hee Jung Nam, Seoul Metropolitan Eunpyong Hospital, Korea
  • Dr Kyung Sue Hong, Sungkyunkwan University School of Medicine, Korea
Risk factors as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study
  • Dr Mauricio Tohen, UT Health Science Center, United States
Serum BDNF and cytokines levels in anti-depressant free late-life depression patients: effects of age of depression onset and clinical characteristics
  • Breno S Diniz, Faculty of Medicine, University of Sao Paulo, Brazil
Prevalence and disability of DSM-IV bipolar disorder in Korean general population survey
  • Dr Sung Man Chang, Department of Psychiatry, Kyungpook National University School of Medicine, Daegu, Korea, Korea
Risk taking behavior in euthymic patients with bipolar disorder and their first-degree relatives
  • Ceren Hidiroglu, Dokuz Eylul University, Turkey
  • Professor Aysegul Ozerdem, Dokuz Eylul University, Turkey
Postural assessment in major depressive disorder: comparisons between recurrent and non-recurrent depression
  • CJZ Janette Zamudio Canales, Mood Disorders Unit (PROGRUDA), Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil, Brazil
The effect of antidepressant treatment on quality of life in patients with major depressive disorder
  • Omer Aydemir, Department of Psychiatry, Celal Bayar University, Manisa, Turkey
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
  • Dr Elisa Brietzke, Bipolar Disorder Program and Molecular Psychiatry Unit, Hospital de Clínicas de Porto Alegre, UFRGS, Brazil., Brazil
Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder
  • Dr Elisa Brietzke, Bipolar Disorder Program, Federal University of Rio Grande do Sul, Porto Alegre, Brazil, Brazil
Treatment of manic patients during hospitalization – a retrospective chart review in 2004-2008: What has changed?
  • Omer Aydemir, Dept. of Psychiatry, Celal Bayar Uni., Manisa, Turkey
Electroconvulsive therapy in the treatment of hospitalized manic patients in turkey: retrospective naturalistic one year data
  • Dr Numan Konuk, Istanbul University, Cerrahpasa Medical Faculty, Turkey
Combined emotional and affective temperament scale: concurrent validity against temperament and character inventory-revised
  • Dr Luísa W Bisol, Hospital São Lucas da PUCRS, Brazil
  • Dr Diogo R Lara, Pontifícia Universidade Católica do Rio Grande do Sul / Hospital São Lucas da PUCRS, Brazil
Serum thiobarbituric acid reactive substances in bipolar disorder during mania and schizophrenia: a biomarker with possible diagnostic implications
  • Dr Brisa S Fernandes, Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Brazil, and INCT for Tra, Brazil
Meta-analysis of epidemiological studies of pediatric bipolar disorder
  • Dr Eric A Youngstrom, University of North Carolina at Chapel Hill, United States
Biomarkers of oxidative stress in schizophrenic and bipolar patients during manic episode
  • Dr Keila M Ceresér, Hospital de Clínicas de Porto Alegre, INCT Translational Medicine, Brazil
  • Dr Clarissa S Gama, Hospital de Clínicas de Porto Alegre, INCT Translational Medicine, Brazil
The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer
  • Michael Bauer, Technische Universität Dresden, Germany
Clinical correlates of eating disorders comorbidity in women with bipolar disorder type 1
  • Dr Elisa Brietzke, Bipolar Disorder Research Program, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil, Brazil
Which depressive symptoms interfere most with work functioning in patients with bipolar disorder?
  • Dr Raymond W Lam, University of British Columbia, Canada
Altered white matter connectivity and water diffusivity in bipolar I and II disorder: a diffusion tensor imaging study
  • Dr Tae Hyon Ha, Seoul National University Bundang Hospital, Korea
Controlled study of group cognitive behavioral therapy for bipolar disorder
  • Psych Bernardo C Gomes, University of São Paulo School of Medicine, Brazil
Metabolic syndrome and associated risk factors in maintenance treatment of bipolar disorder with ziprasidone adjunctive therapy
  • Cedric O'Gorman, Pfizer Inc., United States
Addressing the need for a disorder-specific quality of life scale for bipolar disorder: psychometric properties of the quality of life in bipolar disorder (QoL.BD)
  • Assoc Prof Greg Murray, Swinburne University of Technology, Australia
Association between emotional and affective temperament and professions
  • Dr Alexandre Schmidt, Psychiatry Department of São Lucas Hospital (PUCRS), Brazil
Mania in a man treated with modafinil
  • Dr Özge G DOĞANAVŞARGİL, Akdeniz University Psychiatry Department / Antalya, Turkey
Maintenance treatment with quetiapine added to either lithium or divalproex in bipolar I disorder
  • Dr Trisha Suppes, Stanford Medical Center and VA Palo Alto Health Care System, United States
Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder
  • Dr Eduard Vieta, University of Barcelona, Spain
Comparison between clinical characteristics of suicide attempters and non-attempters in a sample of bipolar disorder patients with mania as first episode polarity
  • Lena N Abreu, Bipolar Disorder Research Program, Institute of Psychiatry, University of São Paulo Medical School, Brazil
  • Elisa Brietzke, Bipolar Disorder Research Program, Institute of Psychiatry, University of São Paulo Medical School. Bipolar Disorder Program,, Brazil
Hypomanic symptoms in schizophrenia and other psychotic disorders
  • Dr Kürşat ALTINBAŞ, Bakırköy Research and Training Hospital for Psychiatry, Neurology& Neurosurgery Raşit Tahsin Mood Disorders Outpatien, Turkey
  • Dr Sinan Gülöksüz, Bakırköy Research and Training Hospital for Psychiatry, Neurology& Neurosurgery, Turkey
  • Assoc Prof Dr Timuçin E Oral, Bakirkoy State Hospital, Turkey
Treatment outcomes based on disease severity for subjects with bipolar I disorder treated with ziprasidone plus a mood stabilizer
  • Dr Cedric O’Gorman, Pfizer Inc, United States
Effects of fasting over bipolar patients during the month of Ramadan
  • Dr Ilker Kucukparlak, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery,, Turkey
Preliminary data on effect of ECT in uni- and bipolar depression as measured by Antonovsky sense of coherence test
  • John Erik Berg, Blakstad Hospital, Vestre Viken Health Trust, Box 83, 1309 Rud, Norway, Norway
A possible association between creativity and schizotypy in bipolar illness
  • Prof Janusz K Rybakowski, Poznan University of Medical Sciences, Poland
Attention deficit hyperactivity symptoms predicted mixed symptoms of bipolar disorder in adolescents
  • Dr Chin-Bin Yeh, Tri-Service General Hospital, Graduate Institute of Medical Sciences, National Defense Medical School, Taiwan
Cytokine levels in euthymic bipolar patients
  • Assoc Prof Dr Timucin Oral, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Turkey
Results of a double-blind, randomized, dose-titration, placebo controlled multicenter trial (SCO/BIA-2093-203 study) on safety and efficacy of eslicarbazepine acetate (BIA 2-093) for acute manic episodes associated with biopolar I disorder
  • Dr Brigitte Robertson, Sepracor Inc., United States
Impact of subdepressive simptoms in quality of life of bipolar patients from mood disorder clinic of Instituto Psiquiatrico "Dr. José Horwitz B", Santiago, Chile
  • Paul Vöhringer, Hospital Clinico Universidad de Chile. Instituto Psiquiatrico, Chile
Adjudicating cognitive endophenotypes for bipolar disorder and schizophrenia
  • Ms Bianca J Lino, University of New South Wales, Australia
Intimate and social relationships in the adult children of bipolar mothers – a controlled pilot study: I. Attachment, separation anxiety and social support
  • Psychologist Cemile Gürdal, Ege University, Turkey
  • Professor Simavi Vahip, Ege University, Turkey
Complement system in bipolar disorders and schizophrenia: C3 and C4
  • Dr Brisa S Fernandes, Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Brazil, and INCT for Tra, Brazil
Bipolarity in eating disorder: comparison of hcl-32 and bipolarity index
  • Dr Rodolfo N Campos, Mood Disorders Unit (GRUDA), Department and Institute of Psychiatry, School of Medicine of the University of São Paulo, Brazil
Alterations in levels of cytokines and adipokines over 2-year follow-up in patients with bipolar disorder
  • Dr Valerie H Taylor, McMaster University, Canada
Reaction time-an effective tool in measurement of neurocognitive dysfunction in bipolar affective disorder
  • Dr Amit Nijhawan, Mahatma Gandhi Medical College, India
Vaproate associated reproductive and sexual dysfunctions: are epileptic men at greater risk than bipolar men?
  • Ass Prof Fisun Akdeniz, Ege University, School of Medicine, Department of Psychiatry, Turkey
Orbitofrontal dysfunction during reward and punishment anticipation in mania
  • Michael Bauer, Dpt. Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Dresden, Germany, Germany
Difficult management of an early onset case of bipolar disorder
  • Mr Wagner S Gurgel, Federal University of Ceará, Brazil
  • Dr Valeria B N Souza, Federal University of Ceará, Brazil
  • Mr Diego B Rebouças, Federal University of Ceará, Brazil
  • Dr Fabio G M Souza, Federal University of Ceará, Brazil
Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain
  • Morgana Moretti, University of Southern Santa Catarina, Brazil
The efficacy of quetiapine monotherapy in bipolar II depression: combined data from the BOLDER and EMBOLDEN studies
  • Dr Allan H Young, University of British Columbia, Canada
Brazilian Portuguese validation of Mood Disorder Questionnaire (MDQ)
  • Mr Wagner S Gurgel, Federal University of Ceará, Brazil
  • Dr Fabio G M Souza, Federal University of Ceará, Brazil
Increased risk of hypomanic symptoms during puerperium: a population survey
  • Mr Diego B Rebouças, Federal University of Ceará, Brazil
  • Mr Wagner S Gurgel, Federal University of Ceará, Brazil
  • Dr Fabio G M Souza, Federal University of Ceará, Brazil
Effect of acute administration of fenproporex on mitochondrial respiratory chain in the brain of adult rats
  • Gislaine T Rezin, Universidade do Extremo Sul Catarinense, Brazil
Perception of disease and pathways to care in bipolar disorder
  • Dr Ingrid Vargas-Huicochea, Universidad Nacional Autonoma de Mexico UNAM, Mexico
Decreased cellular viability in SH-SY5Y neuroblastoma cell line induced by incubation with serum from manic bipolar patients
  • Dr Flávio P Kapczinski, INCT Translational Medicine, Brazil
Psychiatric hospitalizations due to bipolar disorder, major depression disorder and schizophrenia in Rio Grande do Sul, Brazil
  • Dr Brisa S Fernandes, Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Brazil, and INCT for Tra, Brazil
Mass spectrometry of synaptosome after treatment with m-amphetamine as a potential means to investigate the pathophysiology of bipolar disorder
  • Dr Aroldo A Dargél, Bipolar Disorder Program, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil, Brazil
Resource utilization and cost estimation in first manic episode in bipolar disorders: follow-up from the first episode to the next relapse
  • Dr Claudia Becerra-Palars, Affective Disorders Clinic, Instituto Nacional de Psiquiatría, Mexico
Substance abuse or dependence in subjects with bipolar disorder: influence in clinical course
  • Dr Ivan Marin, Instituto Nacional de Psiquiatría "Ramón de la Fuente", Mexico
Factors affecting weight in subjects with an episode of mania in the first month of treatment
  • Dr Sam Calvin Nova Bethania, St Johns Medical College, India
Change in the rate of metabolic syndrome in patients with schizophrenia and bipolar disorder in the course of treatment
  • Dr Eun Young Kim, Seoul National University College of Medicine, Korea
Quantitative mapping of deleted mitochondrial DNA in transgenic mice exhibiting bipolar disorder-like phenotypes
  • Atsushi Takata, RIKEN Brain Science Institute, Japan
Significant decrease of EEG alpha activity and alpha response in bipolar patients
  • Professor Aysegul Ozerdem, Dokuz Eylul University Medical School, Turkey
Long distance gamma (28-48 Hz) coherence decreases under cognitive load in drug free euthymic patients with bipolar disorder
  • Professor Aysegul Ozerdem, Dokuz Eylul University Medical School, Turkey
Patients with bipolar disorder can improve in some cognitive domains under valproate monotherapy
  • Professor Aysegul Ozerdem, Dokuz Eylul University Medical School, Turkey
Early functional recovery predicts engagement in psychological therapy for first episode bipolar disorder
  • Dr Craig A Macneil, Orygen Youth Health Research Centre, University of Melbourne, Australia
An investigation of the impact of substance use on the outcomes of first episode mania
  • Dr Craig A Macneil, Orygen Youth Health Research Centre, Australia
Validation and clinical utility study of the MDQ in a Chilean outpatient sample
  • Dr Paul Vöhringer, Hospital Clínico Universidad de Chile. Instituto Psiquiátrico, Chile
Caregiver depression and youth report of depression and mania symptoms predict family functioning
  • Dr Eric A Youngstrom, University of North Carolina at Chapel Hill, United States
Psychotic symptoms and brain volumes in first episode patients with bipolar disorder: is there a connection? data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)
  • Mauricio Kunz, University of British Columbia, Canada
Comparison of creatine kinase levels in depressed, manic and euthymic patients with bipolar disorder
  • Gustavo Feier, University of Southern Santa Catarina, Brazil
  • Samira S Valvassori, University of Southern Santa Catarina, Brazil
Validity of the "national institutes of mental health life chart - self version" (NIHM-SLCM)
  • Dr Christoph Born, Department of Psychiatry, Ludwig Maximilians-University, Munich, Germany, Germany
Psychopathologic and neurocognitive features of bipolar offspring in a genetically isolated population
  • Dr Juan D Palacio, University of Antioquia, Colombia
A new paradigm of neurofunctional and neurocognitive correlation in bipolar disorder
  • Dr Carlos A Lopez-Jaramillo, Universidad De Antioquia, Colombia
Neuropsychological assessment of euthymic bipolar patients in a Chilean outpatient clinic
  • Mr Raul Sanchez, Pontificia Universidad Catolica de Chile, Chile
Differences in the antidepressant effect of right and left repetitive transcranial magnetic stimulation assessed item by item with Hamilton depression rating scale
  • Dr Francisco Romo
Co-morbidity and psychiatric family history in bipolar disorder (BD) from a Chilean specialist outpatient clinic
  • Mr Raul F Sanchez, Pontificia Universidad Catolica de Chile, Chile
Key issues in bipolar disorder: a global survey of patients, carers, and health care professionals
  • Professor Michael Berk, The University of Melbourne, Australia
The International Society for Bipolar Disorder (ISBD) work group on mixed states and treatment response
  • Dr Mark A Frye, Mayo Clinic, United States